Company Filing History:
Years Active: 2014-2025
Title: The Innovative Contributions of Jonathan Albert Back
Introduction
Jonathan Albert Back, an accomplished inventor based in La Chaux-de-Fonds, Switzerland, has made significant strides in the field of biomedicine. With a portfolio that boasts six patents, Back is recognized for his innovative solutions aimed at improving therapeutic approaches and advancing research in antibody technology.
Latest Patents
Among his notable patents, Back's work on "Antibodies that bind to OX40 and their uses" stands out. This invention refers to antagonist antibodies or fragments that interact with human OX40, designed with specific amino acid sequences that enhance their therapeutic potential. Additionally, his patent on "CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production" showcases his ability to create complex immunoglobulins targeting both human CD3 and CD38 antigens. This advancement opens avenues for new therapeutic and diagnostic applications, demonstrating the practicality and importance of his inventions.
Career Highlights
Throughout his career, Back has associated with reputable companies such as Ichnos Sciences SA and Glenmark Pharmaceuticals SA, where he has played a crucial role in research and development. His work has contributed to the advancement of innovative medical treatments, emphasizing his commitment to improving healthcare outcomes.
Collaborations
Working alongside talented colleagues like Rami Lissilaa and Samuel Hou, Back has fostered collaborations that enhance his research and development endeavors. These partnerships not only bolster his contributions but also reflect a strong network within the scientific community, which often leads to groundbreaking discoveries.
Conclusion
Jonathan Albert Back continues to be a pivotal figure in the realm of biomedical innovations. His extensive knowledge and inventive spirit manifest in his patents, positively impacting the field of medicine and providing new therapeutic techniques. As a dedicated inventor, Back's future contributions promise to further elevate the standards of medical research and development.